Safety of a weekly administration of 7.5 mg/kg of liposomal amphotericin B for antifungal prophylaxis in patients receiving high-dose corticosteroids for acute GvHD after reduced-intensity conditioning allogeneic stem cell transplantation

被引：0
作者：
El-Cheikh, J [1 ]
Faucher, C [1 ]
Furst, S [1 ]
de Lavallade, H [1 ]
Blaise, D [1 ]
Mohty, M [1 ]
机构：
[1] Inst J Paoli I Calmettes, F-13009 Marseille, France
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S185 / S185
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of two regimens of high-dose liposomal amphotericin B for prophylaxis of invasive fungal infection in allogeneic haematopoietic stem cell transplantation: a comparative retrospective single-centre study
    Chakrabartty, J.
    Pavlu, J.
    Neave, E. L.
    Eguialde, M. L.
    O'Shea, D.
    Giles, C.
    Goldman, J.
    Kirschke, S.
    Kanfer, E.
    Kishore, B.
    MacDonald, D.
    Milojkovic, D.
    Marin, D.
    Rahemtulla, A.
    Olavarria, E.
    Apperley, J.
    Rezvani, K.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S131 - S131
  • [42] Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia
    N. Kröger
    M. Bornhäuser
    G. Ehninger
    R. Schwerdtfeger
    H. Biersack
    H. G. Sayer
    H. Wandt
    K. Schäfer-Eckardt
    J. Beyer
    M. Kiehl
    A. R. Zander
    Annals of Hematology, 2003, 82 : 336 - 342
  • [43] The results of allogeneic haematopoietic stem cell transplantation after full and reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin in patients with acute myeloid leukaemia
    Ozdogu, H.
    Boga, C.
    Yeral, M.
    Asma, S.
    Kozanoglu, I.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S93 - S93
  • [44] Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia
    Kröger, N
    Bornhäuser, M
    Ehninger, G
    Schwerdtfeger, R
    Biersack, H
    Sayer, HG
    Wandt, H
    Schäfer-Eckardt, K
    Beyer, J
    Kiehl, M
    Zander, AR
    ANNALS OF HEMATOLOGY, 2003, 82 (06) : 336 - 342
  • [45] Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioning
    Harada, Kaito
    Yanada, Masamitsu
    Machida, Shinichiro
    Kanamori, Heiwa
    Onizuka, Makoto
    Ozawa, Yukiyasu
    Kobayashi, Hikaru
    Sawa, Masashi
    Katayama, Yuta
    Ohashi, Kazuteru
    Kanda, Junya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Yano, Shingo
    LEUKEMIA & LYMPHOMA, 2019, 60 (06) : 1493 - 1502
  • [46] Reduced-intensity conditioning and allogeneic stem cell transplantation is an effective treatment for high-risk acute myeloid leukemia patients in first complete remission
    Hemmati, P.
    Terwey, T.
    Massenkeil, G.
    le Coutre, P.
    Neuburger, S.
    Vuong, L.
    Doerken, B.
    Arnold, R.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S105 - S105
  • [47] Frequency of Invasive Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation Conditioned with Reduced BUCY2 and Antifungal Prophylaxis with Low Dose Amphotericin B
    Armillas Canseco, Flor Maria
    Rivera Franco, Monica M.
    Leon Rodriguez, Eucario
    Terrazas Marin, Ricardo Antonio
    BLOOD, 2015, 126 (23)
  • [48] Lenalidomide plus donor lymphocytes infusion after allogeneic stem cell transplantation with reduced-intensity conditioning in patients with high- risk multiple myeloma
    El Cheikh, J.
    Crocchiolo, R.
    Stoppa, A. M.
    Furst, S.
    Castagna, L.
    Faucher, C.
    Granata, A.
    Oudin, C.
    Ladaique, P.
    De Colella, J. M. Schiano
    Lemarie, C.
    Calmels, B.
    Chabannon, C.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S204 - S204
  • [49] Impact of Postremission Consolidation Chemotherapy on Outcome After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia in First Complete Remission
    Yeshurun, Moshe
    Labopin, Myriam
    Blaise, Didier
    Cornelissen, Jan J.
    Sengeloev, Henrik
    Vindelov, Lars
    Kuball, Juergen
    Chevallier, Patrice
    Craddock, Charles
    Socie, Gerard
    Bilger, Karin
    Schouten, Harry C.
    Fegueux, Nathalie
    Goker, Hakan
    Maertens, Johan
    Bunjes, Donald
    Arnold, Renate
    Nagler, Arnon
    Mohty, Mohamad
    CANCER, 2014, 120 (06) : 855 - 863
  • [50] Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia
    Krejci, Marta
    Doubek, Michael
    Dusek, Jaroslav
    Brychtova, Yvona
    Racil, Zdenek
    Navratil, Milan
    Tomiska, Miroslav
    Horky, Ondrej
    Pospisilova, Sarka
    Mayer, Jiri
    ANNALS OF HEMATOLOGY, 2013, 92 (10) : 1397 - 1403
12345